Pharmafile Logo
Pharmafocus logo
Advanced Search

Industry reputation under fire at home and abroad

October 31, 2003

Continuing conflict over access to medicines in developing countries and growing distrust of big pharma in domestic markets is threatening …

News

Germany delay undermines Crestor confidence

October 31, 2003

AstraZeneca's cholesterol treatment Crestor has been dealt a serious blow following Germanys withdrawal from a pan-European approval process.Germany, the EU's …

News

Parliamentary showdown for foundation trust plans

October 31, 2003

Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …

News

Smallpox vaccine puts Acambis into profit

October 31, 2003

Vaccine company Acambis has joined rivals PowderJect and Celltech in the elite group of profitable UK biotech companies.The company recorded …

News

Shire appoints Emmens as new chief executive

October 31, 2003

Matthew Emmens, former head of Merck KGaA's global prescription group, has been appointed as the new Chief Executive of Shire …

News

Paediatric trials to be mandatory in US

October 31, 2003

Plans to make clinical trials mandatory for all drugs intended for children are progressing in the US.The Paediatric Research Equity …

News

Savings boost GSK outlook

October 31, 2003

News

Pfizer ends obesity drug partnership

October 31, 2003

News

Foundation status offered to 38 more trusts

October 31, 2003

A further 38 hospital have been invited to apply for foundation trust status after winning three stars in the recent …

News

Doubts over pipeline cloud Aventis results

October 31, 2003

Aventis may struggle to replace revenue from its ageing blockbusters despite a strong performance in the second quarter, according to …

News

BMS and Lilly exceed expectations

October 31, 2003

Strong sales of established and new products in the second quarter saw both Bristol-Myers Squibb and Eli Lilly beat analysts' …

News

Smooth transition from old to new for AstraZeneca

October 31, 2003

Growth in new products are helping to plug the sizeable gap left by three of AstraZeneca's ageing blockbusters Prilosec (Losec), …

News

Weak dollar contains Sanofi growth

October 31, 2003

The weakness of the US dollar more than halved Sanofi-Synthelabo's earnings in the first half of this year, but disguised …

News

Heart failure guidelines recommend ACE inhibitors

October 31, 2003

ACE inhibitors have been recommended as first line treatment for chronic heart failure as part of a comprehensive set of …

News

Media training company launched

October 31, 2003

A new training agency specialising in preparing pharmaceutical spokespeople to deal with modern media techniques has been launched.Asparagus Media, set …

News

Industry could gain access to yellow card data

October 31, 2003

The pharmaceutical industry could be granted access to data from the UK's Yellow Card adverse effect warning system to assist …

News

Celebrex to gain orphan drug indication

October 31, 2003

Pfizer's blockbuster arthritis drug Celebrex is set to gain a European orphan drug licence for the treatment of a rare …

News

Challenging second quarter for big pharma

October 31, 2003

Generic competition and wholesaler de-stocking are among the problems besetting two of the industry's biggest hitters, GlaxoSmithKline and AstraZeneca.Deutsche Bank …

News

NICE suspends breast cancer appraisal to await data

October 31, 2003

News

NHS leaders pour scorn on star ratings

October 31, 2003

New star ratings for all NHS trusts have been attacked by leaders in primary and secondary care, who say they …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026